Voyager Therapeutics Statistics
NASDAQ: VYGRHealthcareBiotechnologyUSD
2.47+0.01 (+0.41%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Voyager Therapeutics by the numbers
Voyager Therapeutics has a market capitalization of $152.2 million based on 61.62M shares outstanding. With trailing EPS of $-1.82, Voyager Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.0% below its 50-day average and 32.1% below its 200-day average.
Average daily trading volume is 563.34K shares, or about $1.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VYGR valuation vs. peer median
| Metric | VYGR | Peer median | Difference |
|---|---|---|---|
| Market cap | $152.20M | $155.26M | -2% |
| Avg. volume | 563.34K | 616.95K | -9% |
Peer median across 8 companies: ABOS, TARA, CDXS, KRRO, CHRS, NERV, ALXO, MENS.
Valuation
- Market cap
- $152.20M
- EPS (TTM)
- $-1.82
- Shares outstanding
- 61.62M
Price and trading
- Previous close
- 2.46
- Open
- 2.44
- Day range
- 2.41 – 2.50
- 52-week range
- 2.39 – 5.55
- 52-week change
- -47.78%
- Beta
- —
- Volume
- 762.91K
- Average volume
- 563.34K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 6, 2026
Additional statistics
- Market Cap
- 152.20M
- Forward Pe
- -1.93
- Eps
- -1.82
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.55
- Week52 Low
- 2.39
- Avg Volume
- 563.34K
- Shares Outstanding
- 61.62M
- Ma50
- 3.13
- Ma200
- 3.64
- Earnings Date
- Aug 6, 2026
- Pct From52w High
- -55.50%
- Pct From52w Low
- 3.35%